Massachusetts finally approved their annual state budget -- and it did not include the repeal of the state's pharmaceutical Code of Conduct and restrictions on gifts to physicians as overwhelmingly approved by the House.

So the status quo remains as such in Massachusetts for pharmaceutical marketing research with health care professionals and blinded marketing research is still kosher.